Kuglin B - Search Results

1

Linear loss of insulin secretory capacity during the last six months preceding IDDM. No effect of antiedematous therapy with ketotifen.

Böhmer KP, Kolb H, Kuglin B, Zielasek J, Hübinger A, Lampeter EF, Weber B, Kolb-Bachofen V, Jastram HU, Bertrams J, et al. Böhmer KP, et al. Among authors: kuglin b. Diabetes Care. 1994 Feb;17(2):138-41. doi: 10.2337/diacare.17.2.138. Diabetes Care. 1994. PMID: 8137684 Clinical Trial.

2

Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.

Böhmer K, Keilacker H, Kuglin B, Hübinger A, Bertrams J, Gries FA, Kolb H. Böhmer K, et al. Among authors: kuglin b. Diabetologia. 1991 Nov;34(11):830-4. doi: 10.1007/BF00408359. Diabetologia. 1991. PMID: 1769442

3

Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment.

Kuglin B, Gries FA, Kolb H. Kuglin B, et al. Diabetes. 1988 Jan;37(1):130-2. doi: 10.2337/diab.37.1.130. Diabetes. 1988. PMID: 3275554

4

Antibodies to proinsulin and insulin as predictive markers of type 1 diabetes.

Kuglin B, Rjasanowski I, Bertrams J, Gries FA, Kolb H, Michaelis D. Kuglin B, et al. Diabet Med. 1990 May;7(4):310-4. doi: 10.1111/j.1464-5491.1990.tb01395.x. Diabet Med. 1990. PMID: 2140083

5

Proinsulin autoantibodies: association with type I diabetes but not with islet cell antibodies, insulin autoantibodies or HLA-DR type.

Kuglin B, Halder B, Bertrams J, Grüneklee D, Gries FA, Kolb H. Kuglin B, et al. J Autoimmun. 1990 Oct;3(5):573-7. doi: 10.1016/s0896-8411(05)80023-x. J Autoimmun. 1990. PMID: 2252525

6

Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus.

Kuglin B, Bertrams J, Linke C, Gries FA, Kolb H. Kuglin B, et al. Klin Wochenschr. 1989 Jan 20;67(2):66-73. doi: 10.1007/BF01735654. Klin Wochenschr. 1989. PMID: 2646470

7

[Early diagnosis of type-1 diabetes. Limits, possibilities and outlook].

Kuglin B, Bertrams J, Kolb H, Gries FA. Kuglin B, et al. Dtsch Med Wochenschr. 1989 May 12;114(19):762-7. doi: 10.1055/s-2008-1066671. Dtsch Med Wochenschr. 1989. PMID: 2653770 Review. German. No abstract available.

8

No evidence for increased variation in first phase insulin response to intravenous glucose.

Kuglin B, Hübinger A, Gries FA, Kolb H, Bertrams J. Kuglin B, et al. Diabetologia. 1988 Aug;31(8):637-8. doi: 10.1007/BF00264775. Diabetologia. 1988. PMID: 3065117 No abstract available.

9

Insulin autoantibodies--which method?

Kuglin B, Kolb H, Palmer J. Kuglin B, et al. Lancet. 1989 Sep 9;2(8663):622-3. doi: 10.1016/s0140-6736(89)90746-0. Lancet. 1989. PMID: 2570315 No abstract available.

10

Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement.

Greenbaum CJ, Palmer JP, Kuglin B, Kolb H. Greenbaum CJ, et al. Among authors: kuglin b. J Clin Endocrinol Metab. 1992 May;74(5):1040-4. doi: 10.1210/jcem.74.5.1569152. J Clin Endocrinol Metab. 1992. PMID: 1569152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page